Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S John Weroha

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Genes|June 28, 2023
Characterization and Optimization of Multiomic Single-Cell Epigenomic ProfilingLeticia Sandoval, Wazim Mohammed Ismail, Amelia Mazzone, et al.
NPJ Precision Oncology|July 11, 2025
Lestaurtinib's antineoplastic activity converges on JAK/STAT signaling to inhibit treatment naïve and therapy resistant forms ovarian cancerEsther P B Rodman, Michael J Emch, Xiaonan Hou, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Lestaurtinib's antineoplastic activity converges on JAK/STAT signaling to inhibit advanced forms of therapy resistant ovarian cancerEsther P B Rodman, Michael J Emch, Xiaonan Hou, et al.
Frontiers in Oncology|June 8, 2023
Prognostic stratification of endometrial cancers with high microsatellite instability or no specific molecular profileJesus Gonzalez-Bosquet, S John Weroha, Jamie N Bakkum-Gamez, et al.
Plos One|December 1, 2022
ECPPF (E2F1, CCNA2, POLE, PPP2R1A, FBXW7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancerJesus Gonzalez-Bosquet, S John Weroha, Jamie N Bakkum-Gamez, et al.
NAR Cancer|July 25, 2022
DNA barcoded competitive clone-initiating cell analysis reveals novel features of metastatic growth in a cancer xenograft modelSyed Mohammed Musheer Aalam, Xiaojia Tang, Jianning Song, et al.
Cancer Research|November 23, 2021
Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian CarcinomaArun Kanakkanthara, Xiaonan Hou, Thomas L Ekstrom, et al.
Plos One|January 27, 2021
Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic optionsJesus Gonzalez Bosquet, Qing Zhang, William A Cliby, et al.
Cancer Research|October 8, 2017
Loss of FOXO1 Cooperates with TMPRSS2-ERG Overexpression to Promote Prostate Tumorigenesis and Cell InvasionYinhui Yang, Alexandra M Blee, Dejie Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|May 25, 2026
Factors affecting trainees' preferred timing of clinical clerkships during MD-PhD trainingTaylor P Trentadue, Jessica Weng, Samantha M Bouchal, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Genes|June 28, 2023
Characterization and Optimization of Multiomic Single-Cell Epigenomic ProfilingLeticia Sandoval, Wazim Mohammed Ismail, Amelia Mazzone, et al.
NPJ Precision Oncology|July 11, 2025
Lestaurtinib's antineoplastic activity converges on JAK/STAT signaling to inhibit treatment naïve and therapy resistant forms ovarian cancerEsther P B Rodman, Michael J Emch, Xiaonan Hou, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Lestaurtinib's antineoplastic activity converges on JAK/STAT signaling to inhibit advanced forms of therapy resistant ovarian cancerEsther P B Rodman, Michael J Emch, Xiaonan Hou, et al.
Frontiers in Oncology|June 8, 2023
Prognostic stratification of endometrial cancers with high microsatellite instability or no specific molecular profileJesus Gonzalez-Bosquet, S John Weroha, Jamie N Bakkum-Gamez, et al.
Plos One|December 1, 2022
ECPPF (E2F1, CCNA2, POLE, PPP2R1A, FBXW7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancerJesus Gonzalez-Bosquet, S John Weroha, Jamie N Bakkum-Gamez, et al.
NAR Cancer|July 25, 2022
DNA barcoded competitive clone-initiating cell analysis reveals novel features of metastatic growth in a cancer xenograft modelSyed Mohammed Musheer Aalam, Xiaojia Tang, Jianning Song, et al.
Cancer Research|November 23, 2021
Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian CarcinomaArun Kanakkanthara, Xiaonan Hou, Thomas L Ekstrom, et al.
Plos One|January 27, 2021
Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic optionsJesus Gonzalez Bosquet, Qing Zhang, William A Cliby, et al.
Cancer Research|October 8, 2017
Loss of FOXO1 Cooperates with TMPRSS2-ERG Overexpression to Promote Prostate Tumorigenesis and Cell InvasionYinhui Yang, Alexandra M Blee, Dejie Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|May 25, 2026
Factors affecting trainees' preferred timing of clinical clerkships during MD-PhD trainingTaylor P Trentadue, Jessica Weng, Samantha M Bouchal, et al.
Pageof 9